|
1
|
Bray F, Laversanne M, Sung H, Ferlay J,
Siegel RL, Soerjomataram I and Jemal A: Global cancer statistics
2022: GLOBOCAN estimates of incidence and mortality worldwide for
36 cancers in 185 countries. CA Cancer J Clin. 74:229–263.
2024.PubMed/NCBI
|
|
2
|
Arnold M, Abnet CC, Neale RE, Vignat J,
Giovannucci EL, McGlynn KA and Bray F: Global burden of 5 major
types of gastrointestinal cancer. Gastroenterology.
159:335–349.e15. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhou Y, Song K, Chen Y, Zhang Y, Dai M, Wu
D and Chen H: Burden of six major types of digestive system cancers
globally and in China. Chin Med J (Engl). 137:1957–1964. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sexton RE, Al Hallak MN, Diab M and Azmi
AS: Gastric cancer: A comprehensive review of current and future
treatment strategies. Cancer Metastasis Rev. 39:1179–1203. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sitarz R, Skierucha M, Mielko J, Offerhaus
GJA, Maciejewski R and Polkowski WP: Gastric cancer: Epidemiology,
prevention, classification, and treatment. Cancer Manag Res.
10:239–248. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Niu P, Zhang F, Ma D, Zhou X, Zhu Y, Luan
X, Zhao L, Wang W, Zhang X, Han X, et al: Trends of older gastric
cancer incidence, mortality, and survival in the highest gastric
cancer risk area in China: 2010-2019 and prediction to 2024. BMC
Public Health. 24:24492024. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wu Y, Ma W, Liu W and Zhang S: Lactate: A
pearl dropped in the ocean: An overlooked signal molecule in
physiology and pathology. Cell Biol Int. 47:295–307. 2023.
View Article : Google Scholar
|
|
8
|
Barba I, Carrillo-Bosch L and Seoane J:
Targeting the warburg effect in cancer: Where do we stand? Int J
Mol Sci. 25:31422024. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Paul S, Ghosh S and Kumar S: Tumor
glycolysis, an essential sweet tooth of tumor cells. Semin Cancer
Biol. 86:1216–1230. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shima T, Taniguchi K, Inomata Y, Arima J
and Lee SW: Glycolysis in gastrointestinal stromal tumor: A brief
overview. Neoplasia. 55:1010222024. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xia Y, Zhang L, Ocansey DKW, Tu Q, Mao F
and Sheng X: Role of glycolysis in inflammatory bowel disease and
its associated colorectal cancer. Front Endocrinol (Lausanne).
14:12429912023. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang F, Meng W, Wang B and Qiao L:
Helicobacter pylori-induced gastric inflammation and gastric
cancer. Cancer Lett. 345:196–202. 2014. View Article : Google Scholar
|
|
13
|
Cha B, Lim JW and Kim H: Jak1/Stat3 is an
upstream signaling of NF-κB activation in Helicobacter
pylori-induced IL-8 production in gastric epithelial AGS cells.
Yonsei Med J. 56:862–866. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Salvatori S, Marafini I, Laudisi F,
Monteleone G and Stolfi C: Helicobacter pylori and gastric cancer:
Pathogenetic mechanisms. Int J Mol Sci. 24:28952023. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yang SW, Kwon HS, Sohn IS, Kim YJ and
Hwang HS: Association of Vac A- and Cag A-specific Helicobacter
pylori strain infection with spontaneous preterm birth. J Matern
Fetal Neonatal Med. 30:995–1000. 2017. View Article : Google Scholar
|
|
16
|
D'Elios MM, Manghetti M, De Carli M, Costa
F, Baldari CT, Burroni D, Telford JL, Romagnani S and Del Prete G:
T helper 1 effector cells specific for Helicobacter pylori in the
gastric antrum of patients with peptic ulcer disease. J Immunol.
158:962–967. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kang GH, Lee HJ, Hwang KS, Lee S, Kim JH
and Kim JS: Aberrant CpG island hypermethylation of chronic
gastritis, in relation to aging, gender, intestinal metaplasia, and
chronic inflammation. Am J Pathol. 163:1551–1556. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kwon HJ, Park MI, Park SJ, Moon W, Kim SE,
Kim JH, Choi YJ and Lee SK: Insulin resistance is associated with
early gastric cancer: A prospective multicenter case control study.
Gut Liver. 13:154–160. 2019. View Article : Google Scholar :
|
|
19
|
Noto JM, Piazuelo MB, Romero-Gallo J,
Delgado AG, Suarez G, Akritidou K, Girod Hoffman M, Roa JC, Taylor
CT and Peek RM Jr: Targeting hypoxia-inducible factor-1 alpha
suppresses Helicobacter pylori-induced gastric injury via
attenuation of both cag-mediated microbial virulence and
proinflammatory host responses. Gut Microbes. 15:22639362023.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang M, Zhong J, Song Z, Xu Q, Chen Y and
Zhang Z: Regulatory mechanisms and potential therapeutic targets in
precancerous lesions of gastric cancer: A comprehensive review.
Biomed Pharmacother. 177:1170682024. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Canales J, Valenzuela M, Bravo J,
Cerda-Opazo P, Jorquera C, Toledo H, Bravo D and Quest AF:
Helicobacter pylori induced phosphatidylinositol-3-OH kinase/mTOR
activation increases hypoxia inducible factor-1α to promote loss of
cyclin D1 and G0/G1 cell cycle arrest in human gastric cells. Front
Cell Infect Microbiol. 7:922017. View Article : Google Scholar
|
|
22
|
Wang L and Zhang Z: Diabetes mellitus and
gastric cancer: Correlation and potential mechanisms. J Diabetes
Res. 2023:43884372023. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sheu SM, Cheng H, Kao CY, Yang YJ, Wu JJ
and Sheu BS: Higher glucose level can enhance the H pylori adhesion
and virulence related with type IV secretion system in AGS cells. J
Biomed Sci. 21:962014. View Article : Google Scholar
|
|
24
|
Ikeda F, Doi Y, Yonemoto K, Ninomiya T,
Kubo M, Shikata K, Hata J, Tanizaki Y, Matsumoto T, Iida M and
Kiyohara Y: Hyperglycemia increases risk of gastric cancer posed by
Helicobacter pylori infection: A population-based cohort study.
Gastroenterology. 136:1234–1241. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ahn BY, Kim B, Park S, Kim SG, Han K and
Cho SJ: Cumulative exposure to impaired fasting glucose and
gastrointestinal cancer risk: A nationwide cohort study. Cancer.
130:1807–1015. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tseng CH: The relationship between
diabetes mellitus and gastric cancer and the potential benefits of
metformin: An extensive review of the literature. Biomolecules.
11:10222021. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mansori K, Dehghanbanadaki H, Naderpour S,
Rashti R, Moghaddam AB and Moradi Y: A systematic review and
meta-analysis of the prevalence of Helicobacter pylori in patients
with diabetes. Diabetes Metab Syndr. 14:601–607. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Grant RW, Buse JB and Meigs JB; University
HealthSystem Consortium (UHC) Diabetes Benchmarking Project Team:
Quality of diabetes care in U.S. academic medical centers: Low
rates of medical regimen change. Diabetes Care. 28:337–442. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang X, Zhao G, Shao S and Yao Y:
Helicobacter pylori triggers inflammation and oncogenic
transformation by perturbing the immune microenvironment. Biochim
Biophys Acta Rev Cancer. 1879:1891392024. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Walduck A, Andersen LP and Raghavan S:
Inflammation, immunity, and vaccines for Helicobacter pylori
infection. Helicobacter. 20(Suppl 1): S17–S25. 2015. View Article : Google Scholar
|
|
31
|
Yang XT, Niu PQ, Li XF, Sun MM, Wei W,
Chen YQ and Zheng JY: Differential cytokine expression in gastric
tissues highlights Helicobacter pylori's role in gastritis. Sci
Rep. 14:76832024. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Shoelson SE, Herrero L and Naaz A:
Obesity, inflammation, and insulin resistance. Gastroenterology.
132:2169–2180. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chen B, Liu X, Yu P, Xie F, Kwan JSH, Chan
WN, Fang C, Zhang J, Cheung AHK, Chow C, et al: H: pylori-induced
NF-κB-PIEZO1-YAP1-CTGF axis drives gastric cancer progression and
cancer-associated fibroblast-mediated tumour microenvironment
remodelling. Clin Transl Med. 13:e14812023. View Article : Google Scholar
|
|
34
|
Gong P, Wang J, Wang S, Yang W, Yao W, Li
N, Wang J, Zhao Y, Chen F, Xie J, et al: Metabolomic analysis of
the Puerarin hypoglycemic activity via AMPK-mTOR and PPARγ-NF-κB
signaling pathways. Phytomedicine. 130:1555462024. View Article : Google Scholar
|
|
35
|
Yu H, Lin L, Zhang Z, Zhang H and Hu H:
Targeting NF-κB pathway for the therapy of diseases: Mechanism and
clinical study. Signal Transduct Target Ther. 5:2092020. View Article : Google Scholar
|
|
36
|
de Lima EP, Moretti RC Jr, Torres Pomini
K, Laurindo LF, Sloan KP, Sloan LA, Castro MVM, Baldi E Jr, Ferraz
BFR, de Souza Bast os Mazuqueli Pereira E, et al: Glycolipid
metabolic disorders, metainflammation, oxidative stress, and
cardiovascular diseases: Unraveling pathways. Biology (Basel).
13:5192024.PubMed/NCBI
|
|
37
|
Espinoza García AS, Martínez Moreno AG and
Reyes Castillo Z: The role of ghrelin and leptin in feeding
behavior: Genetic and molecular evidence. Endocrinol Diabetes Nutr
(Engl Ed). 68:654–663. 2021.PubMed/NCBI
|
|
38
|
Khosravi Y, Bunte RM, Chiow KH, Tan TL,
Wong WY, Poh QH, Doli Sentosa IM, Seow SW, Amoyo AA, Pettersson S,
et al: Helicobacter pylori and gut microbiota modulate energy
homeostasis prior to inducing histopathological changes in mice.
Gut Microbes. 7:48–53. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Roper J, Francois F, Shue PL, Mourad MS,
Pei Z, Olivares de Perez AZ, Perez-Perez GI, Tseng CH and Blaser
MJ: Leptin and ghrelin in relation to Helicobacter pylori status in
adult males. J Clin Endocrinol Metab. 93:2350–2357. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Franceschi F, Annalisa T, Teresa DR,
Giovanna D, Ianiro G, Franco S, Viviana G, Valentina T, Riccardo LL
and Antonio G: Role of Helicobacter pylori infection on nutrition
and metabolism. World J Gastroenterol. 20:12809–12817. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Açbay O, Celik AF and Gündoğdu S: Does
Helicobacter pylori-induced gastritis enhance food-stimulated
insulin release? Dig Dis Sci. 41:1327–1331. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Calam J, Gibbons A, Healey ZV, Bliss P and
Arebi N: How does Helicobacter pylori cause mucosal damage? Its
effect on acid and gastrin physiology. Gastroenterology. 113(6
Suppl): S43–S49; discussion S50. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Verhulst PJ and Depoortere I: Ghrelin's
second life: From appetite stimulator to glucose regulator. World J
Gastroenterol. 18:3183–3195. 2012.PubMed/NCBI
|
|
44
|
Isomoto H, Ueno H, Nishi Y, Wen CY,
Nakazato M and Kohno S: Impact of Helicobacter pylori infection on
ghrelin and various neuroendocrine hormones in plasma. World J
Gastroenterol. 11:1644–1648. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Suzuki H, Masaoka T, Hosoda H, Ota T,
Minegishi Y, Nomura S, Kangawa K and Ishii H: Helicobacter pylori
infection modifies gastric and plasma ghrelin dynamics in Mongolian
gerbils. Gut. 53:187–194. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Zhou X, Liu W, Gu M, Zhou H and Zhang G:
Helicobacter pylori infection causes hepatic insulin resistance by
the c-Jun/miR-203/SOCS3 signaling pathway. J Gastroenterol.
50:1027–1040. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Valenzuela MA, Canales J, Corvalán AH and
Quest AF: Helicobacter pylori-induced inflammation and epigenetic
changes during gastric carcinogenesis. World J Gastroenterol.
21:12742–12756. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Xi Y, Zhang XL, Luo QX, Gan HN, Liu YS,
Shao SH and Mao XH: Helicobacter pylori regulates stomach diseases
by activating cell pathways and DNA methylation of host cells.
Front Cell Dev Biol. 11:11876382023. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Ghafari F, Alizadeh AM, Agah S, Irani S
and Mokhtare M: Insulin-like growth factor 1 serum levels in
different stages of gastric cancer and their association with
Helicobacter pylori status. Peptides. 158:1708922022. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Chichirau BE, Diechler S, Posselt G and
Wessler S: Tyrosine kinases in Helicobacter pylori infections and
gastric cancer. Toxins (Basel). 11:5912019. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Choi JH, Cho SO and Kim H: α-Lipoic acid
inhibits expression of IL-8 by suppressing activation of MAPK,
Jak/Stat, and NF-κB in H. pylori-Infected gastric epithelial AGS
cells. Yonsei Med J. 57:260–264. 2016. View Article : Google Scholar :
|
|
52
|
Sokolova O, Vieth M, Gnad T, Bozko PM and
Naumann M: Helicobacter pylori promotes eukaryotic protein
translation by activating phosphatidylinositol 3 kinase/mTOR. Int J
Biochem Cell Biol. 55:157–163. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Heckl SM, Wiesener V, Behrens HM, Ulase D,
Krüger S and Röcken C: The expression of the insulin receptor in
gastric cancer correlates with the HER2 status and may have
putative therapeutic implications. Gastric Cancer. 22:1130–1142.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Yi HK, Hwang PH, Yang DH, Kang CW and Lee
DY: Expression of the insulin-like growth factors (IGFs) and the
IGF-binding proteins (IGFBPs) in human gastric cancer cells. Eur J
Cancer. 37:2257–2263. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Guo C, Chu H, Gong Z, Zhang B, Li C, Chen
J and Huang L: HOXB13 promotes gastric cancer cell migration and
invasion via IGF-1R upregulation and subsequent activation of
PI3K/AKT/mTOR signaling pathway. Life Sci. 278:1195222021.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Ge J and Chen Z, Huang J, Yuan W, Den Z
and Chen Z: Silencing insulin-like growth factor-1 receptor
expression inhibits gastric cancer cell proliferation and invasion.
Mol Med Rep. 11:633–638. 2015. View Article : Google Scholar
|
|
57
|
Hidaka A, Sasazuki S, Goto A, Sawada N,
Shimazu T, Yamaji T, Iwasaki M, Inoue M, Noda M, Tajiri H, et al:
Plasma insulin, C-peptide and blood glucose and the risk of gastric
cancer: The Japan public health center-based prospective study. Int
J Cancer. 136:1402–1410. 2015. View Article : Google Scholar
|
|
58
|
Xu L, Zhou R, Yuan L, Wang S, Li X, Ma H,
Zhou M, Pan C, Zhang J, Huang N, et al: IGF1/IGF1R/STAT3
signaling-inducible IFITM2 promotes gastric cancer growth and
metastasis. Cancer Lett. 393:76–85. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Zong CS, Chan J, Levy DE, Horvath C,
Sadowski HB and Wang LH: Mechanism of STAT3 activation by
insulin-like growth factor I receptor. J Biol Chem.
275:15099–15105. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Kanda N, Seno H, Konda Y, Marusawa H,
Kanai M, Nakajima T, Kawashima T, Nanakin A, Sawabu T, Uenoyama Y,
et al: STAT3 is constitutively activated and supports cell survival
in association with survivin expression in gastric cancer cells.
Oncogene. 23:4921–4929. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Judd LM, Bredin K, Kalantzis A, Jenkins
BJ, Ernst M and Giraud AS: STAT3 activation regulates growth,
inflammation, and vascularization in a mouse model of gastric
tumorigenesis. Gastroenterology. 131:1073–1085. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Scalia P, Giordano A, Martini C and
Williams SJ: Isoform- and paralog-switching in IR-Signaling: When
diabetes opens the gates to cancer. Biomolecules. 10:16172020.
View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Papachristoforou E, Lambadiari V, Maratou
E and Makrilakis K: Association of glycemic indices (Hyperglycemia,
glucose variability, and hypoglycemia) with oxidative stress and
diabetic complications. J Diabetes Res. 2020:74897952020.
View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Zhou Y, Wang Y, Wang S and Shen L:
Hyperglycemia promotes human gastric carcinoma progression via
aquaporin 3. Dig Dis Sci. 60:2338–2345. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Chen F, Zhuang X, Lin L, Yu P, Wang Y, Shi
Y, Hu G and Sun Y: New horizons in tumor microenvironment biology:
Challenges and opportunities. BMC Med. 13:452015. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Liu J and Cao X: Glucose metabolism of
TAMs in tumor chemoresistance and metastasis. Trends Cell Biol.
33:967–978. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Arner EN and Rathmell JC: Metabolic
programming and immune suppression in the tumor microenvironment.
Cancer Cell. 41:421–433. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Reinfeld BI, Madden MZ, Wolf MM, Chytil A,
Bader JE, Patterson AR, Sugiura A, Cohen AS, Ali A, Do BT, et al:
Cell-programmed nutrient partitioning in the tumour
microenvironment. Nature. 593:282–288. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Wang JX, Choi SYC, Niu X, Kang N, Xue H,
Killam J and Wang Y: Lactic acid and an acidic tumor
microenvironment suppress anticancer immunity. Int J Mol Sci.
21:83632020. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Liu Y, Li C, Lu Y, Liu C and Yang W: Tumor
microenvironment-mediated immune tolerance in development and
treatment of gastric cancer. Front Immunol. 13:10168172022.
View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Shi J, Wu Z, Wu X, Huangfu L, Guo T, Cheng
X, Han J, Li Z, Xing X and Ji J: Characterization of
glycometabolism and tumor immune microenvironment for predicting
clinical outcomes in gastric cancer. iScience. 26:1062142023.
View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Laplane L, Duluc D, Larmonier N, Pradeu T
and Bikfalvi A: The multiple layers of the tumor environment.
Trends Cancer. 4:802–809. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Boutilier AJ and Elsawa SF: Macrophage
polarization states in the tumor microenvironment. Int J Mol Sci.
22:69952021. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Ren J, Xu B, Ren J, Liu Z, Cai L, Zhang X,
Wang W, Li S, Jin L and Ding L: The Importance of M1-and
M2-polarized macrophages in glioma and as potential treatment
targets. Brain Sci. 13:12692023. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Gambardella V, Castillo J, Tarazona N,
Gimeno-Valiente F, Martínez-Ciarpaglini C, Cabeza-Segura M, Roselló
S, Roda D, Huerta M, Cervantes A and Fleitas T: The role of
tumor-associated macrophages in gastric cancer development and
their potential as a therapeutic target. Cancer Treat Rev.
86:1020152020. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Zhihua Y, Yulin T, Yibo W, Wei D, Yin C,
Jiahao X, Runqiu J and Xuezhong X: Hypoxia decreases macrophage
glycolysis and M1 percentage by targeting microRNA-30c and mTOR in
human gastric cancer. Cancer Sci. 110:2368–2377. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Vitale I, Manic G, Coussens LM, Kroemer G
and Galluzzi L: Macrophages and metabolism in the tumor
microenvironment. Cell Metab. 30:36–50. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Cheng K, Cai N, Zhu J, Yang X, Liang H and
Zhang W: Tumor-associated macrophages in liver cancer: From
mechanisms to therapy. Cancer Commun (Lond). 42:1112–1140. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Wang Y, Zhang J, Shi H, Wang M, Yu D, Fu
M, Qian Y, Zhang X, Ji R, Wang S, et al: M2 Tumor-associated
macrophages-derived exosomal MALAT1 promotes glycolysis and gastric
cancer progression. Adv Sci (Weinh). 11:e23092982024. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Wang ZH, Peng WB, Zhang P, Yang XP and
Zhou Q: Lactate in the tumour microenvironment: From immune
modulation to therapy. EBioMedicine. 73:1036272021. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Gao J, Liang Y and Wang L: Shaping
polarization of tumor-associated macrophages in cancer
immunotherapy. Front Immunol. 13:8887132022. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Tao L, Huang G, Song H, Chen Y and Chen L:
Cancer associated fibroblasts: An essential role in the tumor
microenvironment. Oncol Lett. 14:2611–2620. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Qiu Y, Lu G, Li N, Hu Y, Tan H and Jiang
C: Exosome-mediated communication between gastric cancer cells and
macrophages: Implications for tumor microenvironment. Front
Immunol. 15:13272812024. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Krzysiek-Maczka G, Targosz A, Wrobel T,
Paw M, Szczyrk U, Opila J, Strzalka M, Wierdak M, Major P,
Brzozowski T, et al: Time-extended exposure of gastric epithelial
cells to secretome of Helicobacter pylori-activated fibroblasts
induces reprogramming of gastric epithelium towards
pre-cancerogenic and pro-invasive phenotype. Am J Cancer Res.
12:1337–1371. 2022.PubMed/NCBI
|
|
85
|
Liu Y, Zhang X, Gu W, Su H, Wang X, Wang
X, Zhang J, Xu M and Sheng W: Unlocking the crucial role of
cancer-associated fibroblasts in tumor metastasis: Mechanisms and
therapeutic prospects. J Adv Res. 71:399–413. 2025. View Article : Google Scholar :
|
|
86
|
Jena BC, Das CK, Banerjee I, Bharadwaj D,
Majumder R, Das S, Biswas A, Kundu M, Roy PK, Kundu CN and Mandal
M: TGF-β1 induced autophagy in cancer associated fibroblasts during
hypoxia contributes EMT and glycolysis via MCT4 upregulation. Exp
Cell Res. 417:1131952022. View Article : Google Scholar
|
|
87
|
Sahai E, Astsaturov I, Cukierman E,
DeNardo DG, Egeblad M, Evans RM, Fearon D, Greten FR, Hingorani SR,
Hunter T, et al: A framework for advancing our understanding of
cancer-associated fibroblasts. Nat Rev Cancer. 20:174–186. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Orimo A, Gupta PB, Sgroi DC,
Arenzana-Seisdedos F, Delaunay T, Naeem R, Carey VJ, Richardson AL
and Weinberg RA: Stromal fibroblasts present in invasive human
breast carcinomas promote tumor growth and angiogenesis through
elevated SDF-1/CXCL12 secretion. Cell. 121:335–348. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Pavlides S, Whitaker-Menezes D,
Castello-Cros R, Flomenberg N, Witkiewicz AK, Frank PG, Casimiro
MC, Wang C, Fortina P, Addya S, et al: The reverse Warburg effect:
Aerobic glycolysis in cancer associated fibroblasts and the tumor
stroma. Cell Cycle. 8:3984–4001. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Chen L, Huang L, Gu Y, Cang W, Sun P and
Xiang Y: Lactate-Lactylation hands between metabolic reprogramming
and immunosuppression. Int J Mol Sci. 23:119432022. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Xie J, Wu H, Dai C, Pan Q, Ding Z, Hu D,
Ji B, Luo Y and Hu X: Beyond Warburg effect-dual metabolic nature
of cancer cells. Sci Rep. 4:49272014. View Article : Google Scholar
|
|
92
|
Dang CV: The interplay between MYC and HIF
in the Warburg effect. Ernst Schering Found Symp Proc. 4:35–53.
2007.
|
|
93
|
Kim JW, Tchernyshyov I, Semenza GL and
Dang CV: HIF-1-mediated expression of pyruvate dehydrogenase
kinase: A metabolic switch required for cellular adaptation to
hypoxia. Cell Metab. 3:177–185. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Xiao Y, Liu X, Xie K, Luo J, Zhang Y,
Huang X, Luo J and Tan S: Mitochondrial dysfunction induced by
HIF-1α under hypoxia contributes to the development of gastric
mucosal lesions. Clin Transl Med. 14:e16532024. View Article : Google Scholar
|
|
95
|
Liao M, Yao D, Wu L, Luo C, Wang Z, Zhang
J and Liu B: Targeting the Warburg effect: A revisited perspective
from molecular mechanisms to traditional and innovative therapeutic
strategies in cancer. Acta Pharm Sin B. 14:953–1008. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Liberti MV and Locasale JW: The warburg
effect: How does it benefit cancer cells? Trends Biochem Sci.
41:211–218. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Kooshan Z, Cárdenas-Piedra L, Clements J
and Batra J: Glycolysis, the sweet appetite of the tumor
microenvironment. Cancer Lett. 600:2171562024. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Yoshida GJ: Metabolic reprogramming: The
emerging concept and associated therapeutic strategies. J Exp Clin
Cancer Res. 34:1112015. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Koppenol WH, Bounds PL and Dang CV: Otto
Warburg's contributions to current concepts of cancer metabolism.
Nat Rev Cancer. 11:325–337. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Hayes C, Donohoe CL, Davern M and Donlon
NE: The oncogenic and clinical implications of lactate induced
immunosuppression in the tumour microenvironment. Cancer Lett.
500:75–86. 2021. View Article : Google Scholar
|
|
101
|
Liu Y, Zhang Z, Wang J, Chen C, Tang X,
Zhu J and Liu J: Metabolic reprogramming results in abnormal
glycolysis in gastric cancer: A review. Onco Targets Ther.
12:1195–1204. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Papandreou I, Cairns RA, Fontana L, Lim AL
and Denko NC: HIF-1 mediates adaptation to hypoxia by actively
downregulating mitochondrial oxygen consumption. Cell Metab.
3:187–197. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Lu J, Tan M and Cai Q: The Warburg effect
in tumor progression: Mitochondrial oxidative metabolism as an
anti-metastasis mechanism. Cancer Lett. 356(2 Pt A): 156–164. 2015.
View Article : Google Scholar
|
|
104
|
Yu Y, Jiang Y, Glandorff C and Sun M:
Exploring the mystery of tumor metabolism: Warburg effect and
mitochondrial metabolism fighting side by side. Cell Signal.
120:1112392024. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Liu T, Zhao X, Cai T, Li W and Zhang M:
Metabolic reprogramming in Helicobacter pylori infection: From
mechanisms to therapeutics. Front Cell Infect Microbiol.
15:16780442025. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Ganapathy-Kanniappan S and Geschwind JF:
Tumor glycolysis as a target for cancer therapy: Progress and
prospects. Mol Cancer. 12:1522013. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Zhao Y, Liu H, Riker AI, Fodstad O, Ledoux
SP, Wilson GL and Tan M: Emerging metabolic targets in cancer
therapy. Front Biosci (Landmark Ed). 16:1844–1860. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Ward PS and Thompson CB: Metabolic
reprogramming: A cancer hallmark even warburg did not anticipate.
Cancer Cell. 21:297–308. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Zhang D, Li J, Wang F, Hu J, Wang S and
Sun Y: 2-Deoxy-D-glucose targeting of glucose metabolism in cancer
cells as a potential therapy. Cancer Lett. 355:176–183. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Fontana F, Giannitti G, Marchesi S and
Limonta P: The PI3K/Akt pathway and glucose metabolism: A dangerous
liaison in cancer. Int J Biol Sci. 20:3113–3125. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Liu Q, Liu Z, Zhang X, Zeng A and Song L:
Revisiting of cancer immunotherapy: Insight from the dialogue
between glycolysis and PD-1/PD-L1 axis in the tumor
microenvironment. Int J Biol Sci. 21:1202–1221. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Zhou Y, Chen S, Yang F, Zhang Y, Xiong L,
Zhao J, Huang L, Chen P, Ren L, Li H, et al: Rabeprazole suppresses
cell proliferation in gastric epithelial cells by targeting
STAT3-mediated glycolysis. Biochem Pharmacol. 188:1145252021.
View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Fang Z, Zhang W, Wang H, Zhang C, Li J,
Chen W, Xu X, Wang L, Ma M, Zhang S and Li Y: Helicobacter pylori
promotes gastric cancer progression by activating the
TGF-β/Smad2/EMT pathway through HKDC1. Cell Mol Life Sci.
81:4532024. View Article : Google Scholar
|
|
114
|
Wang TA, Xian SL, Guo XY, Zhang XD and Lu
YF: Combined 18F-FDG PET/CT imaging and a gastric orthotopic
xenograft model in nude mice are used to evaluate the efficacy of
glycolysis-targeted therapy. Oncol Rep. 39:271–279. 2018.
|
|
115
|
Pu Z, Xu M, Yuan X, Xie H and Zhao J:
Circular RNA circCUL3 accelerates the warburg effect progression of
gastric cancer through regulating the STAT3/HK2 Axis. Mol Ther
Nucleic Acids. 22:310–318. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Mueckler M and Thorens B: The SLC2 (GLUT)
family of membrane transporters. Mol Aspects Med. 34:121–138. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Fenske W, Völker HU, Adam P, Hahner S,
Johanssen S, Wortmann S, Schmidt M, Morcos M, Müller-Hermelink HK,
Allolio B and Fassnacht M: Glucose transporter GLUT1 expression is
an stage-independent predictor of clinical outcome in
adrenocortical carcinoma. Endocr Relat Cancer. 16:919–928. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Modi N, Chen YH, Dong XC, Hu XM, Lau GW,
Wilson KT, Peek RM Jr and Chen LF: BRD4 regulates
glycolysis-dependent Nos2 expression in macrophages upon H pylori
infection. Cell Mol Gastroenterol Hepatol. 17:292–308.e1. 2024.
View Article : Google Scholar :
|
|
119
|
Fujii T, Katoh M, Ootsubo M, Nguyen OTT,
Iguchi M, Shimizu T, Tabuchi Y, Shimizu Y, Takeshima H and Sakai H:
Cardiac glycosides stimulate endocytosis of GLUT1 via intracellular
Na+,K+-ATPase α3-isoform in human cancer cells. J Cell Physiol.
237:2980–2991. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Kumagai S, Koyama S, Itahashi K,
Tanegashima T, Lin YT, Togashi Y, Kamada T, Irie T, Okumura G, Kono
H, et al: Lactic acid promotes PD-1 expression in regulatory T
cells in highly glycolytic tumor microenvironments. Cancer Cell.
40:201–218.e9. 2022. View Article : Google Scholar
|
|
121
|
Zhou J, Wang W, Xie Y, Zhao Y, Chen X, Xu
W, Wang Y and Guan Z: Proteomics-based identification and analysis
of proteins associated with Helicobacter pylori in gastric cancer.
PLoS One. 11:e01465212016. View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Liu X, Yang Z, Chen Z, Chen R, Zhao D,
Zhou Y and Qiao L: Effects of the suppression of lactate
dehydrogenase A on the growth and invasion of human gastric cancer
cells. Oncol Rep. 33:157–162. 2015. View Article : Google Scholar
|
|
123
|
Zhao Z, Han F, Yang S, Wu J and Zhan W:
Oxamate-mediated inhibition of lactate dehydrogenase induces
protective autophagy in gastric cancer cells: Involvement of the
Akt-mTOR signaling pathway. Cancer Lett. 358:17–26. 2015.
View Article : Google Scholar
|
|
124
|
Fiume L, Vettraino M, Manerba M and Di
Stefano G: Inhibition of lactic dehydrogenase as a way to increase
the anti-proliferative effect of multi-targeted kinase inhibitors.
Pharmacol Res. 63:328–334. 2011. View Article : Google Scholar
|
|
125
|
Fujiwara S, Kawano Y, Yuki H, Okuno Y,
Nosaka K, Mitsuya H and Hata H: PDK1 inhibition is a novel
therapeutic target in multiple myeloma. Br J Cancer. 108:170–178.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Deng X, Zhao J, Qu L, Duan Z, Fu R, Zhu C
and Fan D: Ginsenoside Rh4 suppresses aerobic glycolysis and the
expression of PD-L1 via targeting AKT in esophageal cancer. Biochem
Pharmacol. 178:1140382020. View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Jia L, Huang S, Yin X, Zan Y, Guo Y and
Han L: Quercetin suppresses the mobility of breast cancer by
suppressing glycolysis through Akt-mTOR pathway mediated autophagy
induction. Life Sci. 208:123–130. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Shiroki T, Yokoyama M, Tanuma N, Maejima
R, Tamai K, Yamaguchi K, Oikawa T, Noguchi T, Miura K, Fujiya T, et
al: Enhanced expression of the M2 isoform of pyruvate kinase is
involved in gastric cancer development by regulating
cancer-specific metabolism. Cancer Sci. 108:931–940. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Wang P, Sun C, Zhu T and Xu Y: Structural
insight into mechanisms for dynamic regulation of PKM2. Protein
Cell. 6:275–287. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Zhao X, Zhu Y, Hu J, Jiang L, Li L, Jia S
and Zen K: Shikonin inhibits tumor growth in mice by suppressing
pyruvate Kinase M2-mediated aerobic glycolysis. Sci Rep.
8:145172018. View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Lu J, Chen M, Gao S, Yuan J, Zhu Z and Zou
X: LY294002 inhibits the Warburg effect in gastric cancer cells by
downregulating pyruvate kinase M2. Oncol Lett. 15:4358–4364.
2018.PubMed/NCBI
|
|
132
|
Chen S, Fisher RC, Signs S, Molina LA,
Shenoy AK, Lopez MC, Baker HV, Koomen JM, Chen Y, Gittleman H, et
al: Inhibition of PI3K/Akt/mTOR signaling in PI3KR2-overexpressing
colon cancer stem cells reduces tumor growth due to apoptosis.
Oncotarget. 8:50476–50488. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Shen Y, Chen M, Huang S and Zou X:
Pantoprazole inhibits human gastric adenocarcinoma SGC-7901 cells
by downregulating the expression of pyruvate kinase M2. Oncol Lett.
11:717–722. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
134
|
Gao S, Song D, Liu Y, Yan H and Chen X:
Helicobacter pylori CagA protein attenuates 5-Fu sensitivity of
gastric cancer cells through upregulating cellular glucose
metabolism. Onco Targets Ther. 13:6339–6349. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
135
|
Hur H, Xuan Y, Kim YB, Lee G, Shim W, Yun
J, Ham IH and Han SU: Expression of pyruvate dehydrogenase kinase-1
in gastric cancer as a potential therapeutic target. Int J Oncol.
42:44–54. 2013. View Article : Google Scholar :
|
|
136
|
King CC and Obonyo M: Helicobacter pylori
modulates host cell survival regulation through the
serine-threonine kinase, 3-phosphoinositide dependent kinase 1
(PDK-1). BMC Microbiol. 15:2222015. View Article : Google Scholar : PubMed/NCBI
|
|
137
|
Tong J, Xie G, He J, Li J, Pan F and Liang
H: Synergistic antitumor effect of dichloroacetate in combination
with 5- fluorouracil in colorectal cancer. J Biomed Biotechnol.
2011:7405642011.
|
|
138
|
Xuan Y, Hur H, Ham IH, Yun J, Lee JY, Shim
W, Kim YB, Lee G, Han SU and Cho YK: Dichloroacetate attenuates
hypoxia-induced resistance to 5-fluorouracil in gastric cancer
through the regulation of glucose metabolism. Exp Cell Res.
321:219–230. 2014. View Article : Google Scholar
|
|
139
|
Zhao M, Wei F, Sun G, Wen Y, Xiang J, Su
F, Zhan L, Nian Q, Chen Y and Zeng J: Natural compounds targeting
glycolysis as promising therapeutics for gastric cancer: A review.
Front Pharmacol. 13:10043832022. View Article : Google Scholar : PubMed/NCBI
|
|
140
|
Han S, Yang S, Cai Z, Pan D, Li Z, Huang
Z, Zhang P, Zhu H, Lei L and Wang W: Anti-Warburg effect of
rosmarinic acid via miR-155 in gastric cancer cells. Drug Des Devel
Ther. 9:2695–2703. 2015.PubMed/NCBI
|
|
141
|
Ai Y, Zhao Z, Wang H, Zhang X, Qin W, Guo
Y, Zhao M, Tang J, Ma X and Zeng J: Pull the plug:
Anti-angiogenesis potential of natural products in gastrointestinal
cancer therapy. Phytother Res. 36:3371–3393. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
142
|
Han JH, Kim M, Kim HJ, Jang SB, Bae SJ,
Lee IK, Ryu D and Ha KT: Targeting lactate dehydrogenase a with
catechin resensitizes SNU620/5FU gastric cancer cells to
5-fluorouracil. Int J Mol Sci. 22:54062021. View Article : Google Scholar : PubMed/NCBI
|
|
143
|
Wang TA, Zhang XD, Guo XY, Xian SL and Lu
YF: 3-Bromopyruvate and sodium citrate target glycolysis, suppress
survivi n, and induce mitochondrial-mediated apoptosis in gastric
cancer cells and inhibit gastric orthotopic transplantation tumor
growth. Oncol Rep. 35:1287–1296. 2016. View Article : Google Scholar :
|
|
144
|
Chen F, Zhuang M, Zhong C, Peng J, Wang X,
Li J, Chen Z and Huang Y: Baicalein reverses hypoxia-induced 5-FU
resistance in gastric cancer AGS cells through suppression of
glycolysis and the PTEN/Akt/HIF-1α signaling pathway. Oncol Rep.
33:457–463. 2015. View Article : Google Scholar
|
|
145
|
Wu J, Zhang X, Wang Y, Sun Q, Chen M, Liu
S and Zou X: Licochalcone A suppresses hexokinase 2-mediated tumor
glycolysis in gastric cancer via downregulation of the Akt
signaling pathway. Oncol Rep. 39:1181–1190. 2018.
|
|
146
|
Xu Y, Wang Q, Zhang L and Zheng M:
2-Deoxy-D-glucose enhances TRAIL-induced apoptosis in human gastric
cancer cells through downregulating JNK-mediated cytoprotective
autophagy. Cancer Chemother Pharmacol. 81:555–564. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
147
|
Wang Y, Wang S, Yang Q, Li J, Yu F and
Zhao E: Norepinephrine enhances aerobic glycolysis and may act as a
predictive factor for immunotherapy in gastric cancer. J Immunol
Res. 2021:55806722021.PubMed/NCBI
|
|
148
|
García-Carracedo D, Villaronga MÁ,
Álvarez-Teijeiro S, Hermida-Prado F, Santamaría I, Allonca E,
Suárez-Fernández L, Gonzalez MV, Balbín M, Astudillo A, et al:
Impact of PI3K/AKT/mTOR pathway activation on the prognosis of
patients with head and neck squamous cell carcinomas. Oncotarget.
7:29780–29793. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
149
|
Sellam LS, Zappasodi R, Chettibi F,
Djennaoui D, Yahi-Ait Mesbah N, Amir-Tidadini ZC, Touil-Boukoffa C,
Ouahioune W, Merghoub T and Bourouba M: Silibinin down-regulates
PD-L1 expression in nasopharyngeal carcinoma by interfering with
tumor cell glycolytic metabolism. Arch Biochem Biophys.
690:1084792020. View Article : Google Scholar : PubMed/NCBI
|
|
150
|
Zhang B, Yang Y, Shi X, Liao W, Chen M,
Cheng AS, Yan H, Fang C, Zhang S, Xu G, et al: Proton pump
inhibitor pantoprazole abrogates adriamycin-resistant gastric
cancer cell invasiveness via suppression of Akt/GSK-β/β-catenin
signaling and epithelial-mesenchymal transition. Cancer Lett.
356(2, Part B): 704–712. 2015. View Article : Google Scholar
|
|
151
|
Stacpoole PW: Review of the pharmacologic
and therapeutic effects of diisopropylammonium dichloroacetate
(DIPA). J Clin Pharmacol J New Drugs. 9:282–291. 1969. View Article : Google Scholar : PubMed/NCBI
|
|
152
|
Raez LE, Papadopoulos K, Ricart AD,
Chiorean EG, DiPaola RS, Stein MN, Rocha Lima CM, Schlesselman JJ,
Tolba K, Langmuir VK, et al: A phase I dose-escalation trial of
2-deoxy-D-glucose alone or combined with docetaxel in patients with
advanced solid tumors. Cancer Chemother Pharmacol. 71:523–530.
2013. View Article : Google Scholar
|
|
153
|
Maher JC, Krishan A and Lampidis TJ:
Greater cell cycle inhibition and cytotoxicity induced by
2-deoxy-d-glucose in tumor cells treated under hypoxic vs aerobic
conditions. Cancer Chemother Pharmacol. 53:116–122. 2004.
View Article : Google Scholar
|
|
154
|
Novack DV: The FOX(O1) blasts off. Cell
Metab. 11:175–176. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
155
|
Michelakis ED, Sutendra G, Dromparis P,
Webster L, Haromy A, Niven E, Maguire C, Gammer TL, Mackey JR,
Fulton D, et al: Metabolic modulation of glioblastoma with
dichloroacetate. Sci Transl Med. 2:31ra342010. View Article : Google Scholar : PubMed/NCBI
|
|
156
|
Chu QS, Sangha R, Spratlin J, Vos LJ,
Mackey JR, McEwan AJ, Venner P and Michelakis ED: A phase I
open-labeled, single-arm, dose-escalation, study of dichloroacetate
(DCA) in patients with advanced solid tumors. Invest New Drugs.
33:603–610. 2015. View Article : Google Scholar : PubMed/NCBI
|
